NKTR 13F Hedge Fund and Asset Management Owners

Data based on most recent fiscal year report
Market Cap	3.944 Billion	Shares Outstanding	175.92 Million	Avg Volume	3.264 Million
1-Yr BETA vs S&P TR	0.829	Current Ratio	17.53	Quick Ratio	17.39

Inhale Therapeutic Systems

Nektar Therapeutics, Inc. Chart by YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Check out our reporting and analysis

MGM insiders bought $22.24 mil of stock. Activist Corvex management and 4 other officers and directors are betting MGM can weather casino shutdown.
via whalewisdomalpha 04/02/2020
Small cap $1 million+ insider buys during the Coronavirus crash. Babies thrown out with the bathwater?
via whalewisdomalpha 03/30/2020
Institutions Were Dumping FedEx’s Stock in The Fourth Quarter 03/30/2020
The WhaleWisdom Insider Sell vs Buy Ratio was this bullish twice before: Nov. 2008 and March 2009. Have we seen the Coronavirus bear market bottom?
via whalewisdomalpha 03/25/2020
Netflix Weathers the Storm 03/23/2020
Michael Burry's Scion fund averaged down on battered Tailored Brands. But the passive investing bubble Burry warned about may be bursting.
via whalewisdomalpha 03/22/2020
Kroger Displays a Steady Rise 03/16/2020
Top Hedge Funds Pile Into Adobe Ahead of First Quarter Results 03/09/2020

Funds Holding NKTR (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Click for Additional Filters

Market Value:

Ranking:

% of portfolio

Refresh

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NKTR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

74.1 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

53.5 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
AJER JEFFREY ROBERT EVP, CHIEF COMMERCIAL OFFICER	Officer	65,471	2020-04-01	3
GERGEL IVAN P.	Director	0	2020-03-20	0
DOBERSTEIN STEPHEN K	Director	0	2020-03-12	3
CHESS ROBERT	Director	276,973	2020-03-11	4
MYRIAM CURET EVP & CHIEF MEDICAL OFFICER	Officer	0	2020-02-28	2
LABRUCHERIE GIL M SVP, COO & CFO	Officer	253,221	2020-02-18	13
ROBIN HOWARD W PRESIDENT & CEO	Officer Director	385,281	2020-02-18	9
THOMSEN JILLIAN B. SVP & CHIEF ACCOUNTING OFFICER	Officer	174,086	2020-02-18	6
ZALEVSKY JONATHAN CHIEF R&D OFFICER	Officer	327,073	2020-02-18	5
KUEBLER CHRISTOPHER A	Director	15,977	2020-01-02	0
WHITFIELD ROY A	Director	218,250	2019-12-18	2
NORTHCOTT JOHN SVP & CHIEF COMMERCIAL OFFICER	Officer	200,000	2019-12-02	2
LINGNAU LUTZ	Director	26,700	2019-09-27	3
GREER R SCOTT	Director	151,583	2019-09-25	1
EASTHAM KARIN	Director	15,000	2019-09-25	1
LORIANNE MASUOKA K. CHIEF MEDICAL OFFICER	Officer	0	2019-08-21	0
NICHOLSON JOHN SVP & CHIEF OPERATING OFFICER	Officer	162,759	2019-08-16	2
CHOWRIRA BHARAT M	Director	10,000	2019-07-01	0
HORA MANINDER SVP PHARMA DEV & MFG OPS	Officer	94,694	2019-05-16	1
WINGER DENNIS L	Director	47,750	2018-08-17	0
HUH HOYOUNG	Director	0	2018-06-22	0
KRIVULKA JOSEPH J	Director	82,000	2017-09-19	0
BROWN MICHAEL A/CA CEO	Officer Director	414,016	2016-06-01	0
WANG SUSAN	Director	9,887	2016-01-25	0
PATTON JOHN STUART	Director	179,876	2014-08-19	0
MEDVE ROBERT SVP & CHIEF MEDICAL OFFICER	Officer	0	2014-02-05	0
GHOSH RINKO CHIEF BUSINESS OFFICER	Officer	0	2013-02-06	0
MOREADITH RANDALL W SVP DRUG DEVELOPMENT	Officer	0	2009-02-23	0
LERNER IRWIN	Director	13,200	2009-01-02	0

Insider Transactions Last 60 Days

Reporting Owners	Transaction Date	Transaction Code	Shares	Share Price	Acquired or Disposed	Shares Owned Following Transaction	Combined shares owned after filing	Direct/Indirect Ownership
CHESS ROBERT - Director	2020-03-11	M	8,000		d	24,000	276,973.00	direct
CHESS ROBERT - Director	2020-03-11	M	8,000	$9.24	d	284,973	276,973.00	direct
CHESS ROBERT - Director	2020-03-11	S	1,200	$17.41	d	276,973	276,973.00	direct
CHESS ROBERT - Director	2020-03-11	S	6,800	$16.68	d	278,173	276,973.00	direct
THOMSEN JILLIAN B. - Officer SVP & CHIEF ACCOUNTING OFFICER	2020-02-18	S	1,394	$22.35	d	174,086	174,086.00	direct
LABRUCHERIE GIL M - Officer SVP, COO & CFO	2020-02-18	S	5,938	$22.35	d	253,221	253,221.00	direct
ZALEVSKY JONATHAN - Officer CHIEF R&D OFFICER	2020-02-18	S	4,774	$22.35	d	327,073	327,073.00	direct
ROBIN HOWARD W - Director - Officer PRESIDENT & CEO	2020-02-18	S	8,448	$22.35	d	384,871	385,281.00	direct
CHESS ROBERT - Director	2020-02-12	S	3,599	$23.72	d	276,973	276,973.00	direct
CHESS ROBERT - Director	2020-02-12	S	4,401	$23.32	d	280,572	276,973.00	direct
CHESS ROBERT - Director	2020-02-12	M	8,000		d	32,000	276,973.00	direct
CHESS ROBERT - Director	2020-02-12	M	8,000	$9.24	d	284,973	276,973.00	direct
THOMSEN JILLIAN B. - Officer SVP & CHIEF ACCOUNTING OFFICER	2020-02-06	M	37,500	$7.21	a	212,980	175,480.00	direct
THOMSEN JILLIAN B. - Officer SVP & CHIEF ACCOUNTING OFFICER	2020-02-06	M	37,500		d	0	175,480.00	direct
THOMSEN JILLIAN B. - Officer SVP & CHIEF ACCOUNTING OFFICER	2020-02-06	S	37,500	$22.78	d	175,480	175,480.00	direct

Nektar Therapeutics, Inc. (NKTR)